Back to search

Belgium· BE-AMP-SAM350305-00

Clopidogrel Teva Pharma 75 mg

A ticlopidine product containing clopidogrel hydrochloride, registered in Belgium by Teva Pharma. The same ATC class is registered in 7 of our 19 countries.

ATC B01AC05

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedClopidogrel Teva Pharma 75 mgATCB01AC05REGISTER NO.BE-AMP-SAM350305-00PACKS LISTED3CHECKEDSeptember 26, 2026

Where it is registered

Ticlopidine is registered in 7 of 19 countries.

Countries holding a registration under ATC B01AC05 (ticlopidine), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 5 of them publish a price we can compare per daily dose

Ticlopidine · ATC B01AC05

7 / 19 countries

  • Belgiumprice
  • Franceprice
  • Germany
  • Italyprice
  • Polandprice
  • Spainprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of ticlopidine costs, country by country.

Normalised to the WHO defined daily dose (0.5 g), the median price runs from $0.25 in Italy to $1.0 in France — a ×4.0 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Ticlopidine · price per daily dose (0.5 g)

USD · FX 28 Sept 2026

  • FR France$1.0
  • ES Spain$0.71
  • IT Italy$0.25
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Clopidogrel Hydrochloride
Manufacturer
Teva Pharma
Country
Belgium (BE)
ATC code
B01AC05
ATC class
Ticlopidine
Defined daily dose
0.5 g, O
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 3

  • be_apb
    2683001
  • be_apb
    2683019
  • be_apb
    2683027

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

318 interactions on record for ticlopidine.

Graded by severity as the source publishes them — 54 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Ticlopidine · interactions on record

318 records

  • 54 severe
  • 124 moderate
  • 36 minor
  • 104 info

Most severe, free to view

  • DalteparinB01AB04severe
  • EnoxaparinB01AB05severe
  • DanaparoidB01AB09severe
  • TinzaparinB01AB10severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Ticlopidine in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ticlopidine products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Aclop, Clopidogrel +pharma
  • Bulgaria · Глопенел, Егитромб
  • Cyprus · Adagrel, Agregex
  • Czechia · Clopidogrel Accord, Clopidogrel Actavis
  • Germany · Clopidogrel, Clopidogrel 1 A Pharma
  • Denmark · Clopidogrel "juta", Clopidogrel Accord
  • Estonia · Clopidogrel Sanoswiss, Trombex
  • Spain · Clopidogrel Almus, Clopidogrel Alter
  • Finland · Clopidogrel, Clopidogrel Orion
  • France · Clopidogrel Accord, Clopidogrel Almus Pharma
  • United Kingdom (Northern Ireland) · Cadix, Clopidogrel
  • Greece · Blodegrel, Carder
  • Croatia · Gardin, Klopidex
  • Hungary · Clopid, Clopidogrel Actavis
  • Ireland · Clodel, Clopidogrel Accord Healthcare
  • Iceland · Clopidogrel Actavis, Clopidogrel Krka
  • Italy · Averelix, Clopidogrel Almus Pharma
  • Liechtenstein · Clopidogrel Ratiopharm, Clopidogrel Teva
  • Lithuania · Clopidogrel Actavis, Clopidogrel Sanoswiss
  • Luxembourg · Clopidogrel (Hcl) Sandoz, Clopidogrel Eg
  • Latvia · Trombex
  • Malta · Clopidogrel Aurobindo, Clopidogrel Azure
  • Netherlands · Clopidogrel (Als Hydrochloride) Sandoz, Clopidogrel Accord
  • Norway · Clopidogrel Accord, Clopidogrel Actavis
  • Poland · Agregex, Areplex
  • Portugal · Clopidogrel Aba Farmoz - Sociedade Técnico Medicinal, Clopidogrel Adapes
  • Romania · Clopidogrel Arena, Clopidogrel Eipico
  • Sweden · Clopidogrel Accord, Clopidogrel Actavis
  • Slovakia · Clopidogrel Actavis, Clopidogrel Medreg

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ad7653d2-39eb-4cc4-bb7b-230299e3419c
GET /v1/drugs/ad7653d2-39eb-4cc4-bb7b-230299e3419c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Film-coated tablet",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "Clopidogrel Teva Pharma 75 mg",
  "name_fr": "Clopidogrel Teva Pharma 75 mg",
  "name_nl": "Clopidogrel Teva Pharma 75 mg",
  "amp_code": "SAM350305-00",
  "strengths": [
    "75.0000"
  ],
  "pack_count": 26,
  "substances": [
    "Clopidogrel Hydrochloride",
    "Clopidogrel"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Ticlopidine",
  "authorisation_numbers": [
    "EU/1/10/649/016",
    "EU/1/09/561/010"
  ]
}

See everything about ticlopidine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.